Barbara Schmidt is a neonatologist and clinical epidemiologist who led several large

international neonatal randomized trials with clinically important, long-term outcomes:

1. Trial of Indomethacin Prophylaxis in Preterms (TIPP)

2. Caffeine for Apnea of Prematurity (CAP) Trial

3. Canadian Oxygen Trial (COT)

These studies were coordinated by the Neonatal Trials Group at McMaster University in

Hamilton, Ontario, Canada and supported by the Canadian Institutes of Health

Research. The CAP trial was chosen by the Society for Clinical Trials for its inaugural

Trial of the Year Award in 2008 (now named the David Sackett Annual Trial of the Year

Award).

Currently, Dr. Schmidt is a Professor (Part-time) in the Department of Health Research

Methods, Evidence, and Impact at McMaster University, and a Professor Emerita at the

University of Pennsylvania in Philadelphia. From 2011 until 2018, she was the principal

investigator for the University of Pennsylvania and Children’s Hospital of Philadelphia in

the Neonatal Research Network of the National Institute of Child Health and Human

Development. Throughout her career, she has mentored talented neonatal trainees who

were enthusiastic about evidence-based neonatal practice and clinical research.

Dr. Schmidt has received the highest honors in her specialty, including the Douglas K

Richardson Award from the Society for Pediatric Research, the Virginia Apgar Award

from the American Academy of Pediatrics, and the Arvo Ylppö Medal from the Finnish

Pediatric Research Foundation. She is a member of the Order of Canada.